Viscoderm Hydrobooster 1x1.1ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
VISCODERM® Hydrobooster from IBSA Derma is a skinbooster of hyaluronic acid cross-linked to a low percentage, formulated from two molecular weights (1,000 and 2,000 kDa) according to the company's hybrid technology. Unlike a filler, it provides no volume and does not modify the contour: it is applied in the dermis to tighten and smooth the superficial wrinkles of the dynamic areas of the face —perioral, periocular and forehead—, where constant muscle movement limits the performance of conventional biostimulants.
- Cross-linked HA 25 mg/g
- Molecular weights 1,000 and 2,000 kDa
- Contents 1 syringe × 1.1 ml
- Needles 2 × 29G ½"
- Protocol 2 sessions / 8 weeks
Composition and technology
- Cross-linked hyaluronic acid: 25 mg/g, obtained by bacterial fermentation, of non-animal origin.
- Degree of cross-linking: deliberately low. Cross-linking provides intradermal persistence and resistance to enzymatic degradation, but it is kept low in order to preserve a fluid gel, without capacity for projection and without risk of nodule formation in areas of high mobility.
- Hybrid technology of two molecular weights: it combines chains of 1,000 kDa and 2,000 kDa. The coexistence of both fractions is the element the manufacturer calls the two expressions of hyaluronic acid: the higher molecular weight fraction sustains hydration and structure, the lower molecular weight fraction favours diffusion and tissue integration.
- Hydrolift® Action: an IBSA Derma concept describing the combined action of intradermal hydration and stretching (hydro-stretch) of superficial lines, with recovery of skin elasticity and structure.
- Positioning: it is not a dermal filler. It acts on texture, elasticity and radiance without altering the facial contours.
Indications and treatment areas
Indicated to restore intradermal hydration and to improve skin structure and elasticity, with a specific focus on areas of movement.
- Perioral area: barcode lines, perioral lines
- Periocular area: eye contour, superficial lines
- Forehead and nasal dorsum
- Dehydrated skin and skin with altered texture
- Acne scars
The manufacturer places the main indication in patients with signs of moderate to advanced ageing (Glogau scale types II and III).
Technique and treatment protocol
- Injection plane: intradermal.
- Needle: 29G ½" (13 mm), 2 units included. Luer-Lock connection.
- Technique: intradermal deposits following the orientation of the lines of the area treated; gentle massage afterwards to even out the product.
- Dose: 1 syringe per session.
- Protocol: 2 sessions at an interval of 2 months (8 weeks).
- Maintenance: repetition of the cycle twice a year.
- Compatible with combined protocols of the IBSA Derma range, both with bio-remodelling (Profhilo) and with cross-linked fillers (Aliaxin), planning the sequence according to clinical judgement.
Technical data
| Manufacturer | IBSA Derma — IBSA Institut Biochimique SA, Switzerland |
|---|---|
| Active substance | Cross-linked hyaluronic acid, 25 mg/g |
| Molecular weights | 1,000 kDa and 2,000 kDa |
| Degree of cross-linking | Low percentage |
| Origin | Bacterial fermentation, non-animal |
| Anaesthetic | Not contained |
| Presentation | 1 pre-filled syringe of 1.1 ml, Luer-Lock connection |
| Needles | 2 × 29G ½" (13 mm) |
| Treatment plane | Intradermal |
| Classification | CE-marked resorbable medical device |
| Use | Qualified healthcare professionals only |
Storage and pack contents
- Storage: at controlled room temperature, protected from direct sunlight and from heat sources. Do not freeze.
- Do not use after the expiry date stated on the pack.
- Single-use product. Do not reuse or re-sterilise.
- The pack contains: 1 pre-filled syringe of 1.1 ml, 2 needles 29G ½", instructions for use and traceability labels for the patient record.
Contraindications and warnings
Contraindications: known hypersensitivity to hyaluronic acid or to any of the components; active skin infection or inflammation in the treatment area, including active herpes simplex; autoimmune diseases; coagulation disorders or anticoagulant therapy; pregnancy and breastfeeding; under 18 years of age.
Warnings: for intradermal use only. Do not inject intravascularly. Do not mix with other products in the same syringe. Do not apply over areas with permanent implants. Do not combine in the same session with laser resurfacing, deep peeling or dermabrasion.
Always consult the instructions for use included in the pack before treatment. The binding contraindications are those set out in the official documentation supplied with the product.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of IBSA Derma. This information sheet does not replace the instructions for use supplied with the product.